Latest Nrf2 Clinical Trials and Research keeps our readers updated on the latest news and scientific research regarding Nrf2, other pathway activation, and signaling. We report on findings by medical professionals from credible sources.


Keep up to date on Nrf2 news and reviews

Nrf2 MS Study
Biogen’s BG-12 has been approved by the FDA and is now marketed under the name Tecfidera. Google News reported 28 Feb 2012 that Biogen Idec has submitted for FDA approval for new drug to treat Multiple Sclerosis. The drug is known as BG-12 (Dimethyl Fuerate). Multiple Sclerosis impacts more that 400, 000 people in the United states and over 2.5 million people worldwide. Biogen is submitting their drug for FDA approval. There are non drug Nrf2 activators on the market.
Estee Lauder
Estée Lauder has unveiled its new anti-aging creme called Revitalizing supreme Global anti-aging creme. The product has been created in response the huge European demand for a simple approach to beauty and skin care. Skin care has become increasingly more complex over the recent years.
  • 1
  • 2
Malcare WordPress Security